These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38558957)

  • 1. Positive contact and empathy as predictors of primary care providers' willingness to prescribe medications for opioid use disorder.
    Dhanani LY; Miller WC; Hall OT; Brook DL; Simon JE; Go V; Franz B
    SSM Ment Health; 2023 Dec; 4():. PubMed ID: 38558957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
    Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
    Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals.
    Franz B; Dhanani LY; Hall OT; Brook DL; Fenstemaker C; Simon JE; Miller WC
    Addict Sci Clin Pract; 2024 Jan; 19(1):7. PubMed ID: 38243307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of medical providers' attitudes about naloxone and people with opioid use disorder and their self-reported "low-barrier" treatment practices.
    Winograd RP; Coffey B; Nance M; Carpenter R
    Addict Behav Rep; 2023 Dec; 18():100514. PubMed ID: 37680698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency.
    Boggiano V; Gilmore Wilson C; Fagan EB; Kirk J; Bossenbroek-Fedoriw K; Tak CR
    J Am Board Fam Med; 2020; 33(6):998-1003. PubMed ID: 33219079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.
    Gregory HM; Hill VM; Parker RW
    Cureus; 2021 Nov; 13(11):e19870. PubMed ID: 34976492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician's Attitudes Toward Patients With Opioid Use Disorder and Use of Medications for Opioid Use Disorder Vary by Training.
    Bailey BC; Sweeney HA; Winstanley EL; Lopez C; Potts L
    Subst Use Addctn J; 2024 Aug; ():29767342241265902. PubMed ID: 39115101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of the Capacity to Treat Chronic Pain and Opioid Use Disorder (CAP-POD) questionnaire.
    Varley AL; Goodin BR; Copes H; Kertesz SG; Fontaine K; Cherrington AL; Hendricks PS
    Implement Res Pract; 2020; 1():2633489520948859. PubMed ID: 37089127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead.
    Dhillon JS; Feulner L; Beitollahi A; Kossen K; Galarneau D
    Ochsner J; 2024; 24(2):108-117. PubMed ID: 38912181
    [No Abstract]   [Full Text] [Related]  

  • 14. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder.
    Robles M; Mortazavi L; Vannerson J; Matthias MS
    Teach Learn Med; 2022; 34(5):514-521. PubMed ID: 33974460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX.
    Potter JS; Finley EP; King VL; Lanham HJ; Schmidt S; Schneegans S; Rosen KD
    J Subst Abuse Treat; 2022 Jun; 137():108688. PubMed ID: 35058105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder.
    Reed MK; Murali V; Sarpoulaki N; Zavodnick JH; Hom JK; Rising KL
    Drug Alcohol Depend Rep; 2022 Dec; 5():100106. PubMed ID: 36844165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
    Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
    Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
    Muzyk A; Smothers ZPW; Collins K; MacEachern M; Wu LT
    Subst Abus; 2019; 40(4):476-483. PubMed ID: 31418645
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
    Krupp J; Hung F; LaChapelle T; Yarrington ME; Link K; Choi Y; Chen H; Marais AD; Sachdeva N; Chakraborty H; McKellar MS
    South Med J; 2023 Apr; 116(4):333-340. PubMed ID: 37011580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why aren't physicians prescribing more buprenorphine?
    Huhn AS; Dunn KE
    J Subst Abuse Treat; 2017 Jul; 78():1-7. PubMed ID: 28554597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.